Laboratorios Farma | ROVI - 贷款资金

金融业

EUR

EUR 799.88M

现金及等价物

EUR 46.11M

EUR 186.09M

EUR 509.33M

EUR 199.84M

EUR 129.3M

股息收益率

2.15

EUR 135.05M

EUR 34.94M

1.99K

EPS每股收益

EUR 1.96

股本和储备

EUR 539.39M

EUR 105.28M

债务利息支出

EUR 699K

EUR 139K

EUR 80.5M

EUR 2.99B

EUR 103.69M

EUR 313.62M

EUR 135.05M

普通股股本

EUR 51.82M

18.78

EUR 26.78M

EUR 448.66M

销售和管理费用

EUR 35.32M

EUR 327.67M

贸易债权人

EUR 107.59M

应收帐款人

EUR 143.38M

	贷款资金	更改		日
Akebia Therapeutics	USD 24.75M		11.64M	2026-06
Alaunos Therapeutics	USD 4.47M		5.85M	2022-06
Almirall	EUR 303.77M		21.04M	2026-06
Avita Medical	AUD 42.24M		1.25M	2024-12
Dianthus Therapeutics	USD 0		0	2024-12
Ionis Pharmaceuticals	USD 1.91B		6.62M	2026-06
IQVIA Holdings	USD 13.7B		284M	2026-06
Laboratorios Farma	EUR 80.5M		28.26M	2024-12
Moderna	USD 597M		6M	2026-06
Organon & Co	USD 8.48B		74M	2026-06
Pharma Mar	EUR 32.13M		1.04M	2026-06
Revvity	USD 2.63B		1.02M	2026-06
Tectonic Therapeutic	USD 17K		26K	2026-03
Viatris	USD 11.61B		801.1M	2026-06
Xeris Pharmaceuticals	USD 188.81M		32.42M	2026-06